21st Austria weekly - Marinomed, Andritz (19/04/2023)

Marinomed: Marinomed Biotech AG achieved istable total revenues of € 11.3 m (2021: € 11.6 m). Cash and cash equivalents increased by 41% to € 8.2 m (2021: € 5.8 m) due to the drawdown of the last tranche of EIB financing and cost-conscious liquidity management. Further investments in Marinomed's future growth path were reflected in the earnings development according to plan. Thus, research and development expenses remained at a high level of € 6.9 m in 2022 (2021: € 7.5 m). The operating result of € -4.9 m was slightly below the prior-year figure of € -4.1 m. Andreas Grassauer, CEO of Marinomed, says: "2022 was another successful year for Marinomed. Although small-cap life science companies like Marinomed were facing increasing pressure in a challenging market environment, we were again able to prove that our Carragelose portfolio is a sustainably growing business. With the Procter & Gamble partnership, we signed one of the most significant deals in the Company's history. Further milestones were the US patent for the Marinosolv technology and the expansion of our Solv4U technology partnerships. This is a solid foundation for achieving operational profitability in the short term and for driving long-term strategic growth projects." 

Andritz: International technology group Andritz and HydrogenPro, a leader in green hydrogen technology and systems, have entered into a partnership to collaborate on scaling up manufacturing and assembly of electrolyzers for the European market. The collaboration will bring together HydrogenPro’s expertise in high-pressure alkaline electrolyzer (AEL) technology with Andritz’s competence in manufacturing and assembly. This non-exclusive partnership will allow Andritz to include HydrogenPro’s technology in its EPC offering of green hydrogen solutions. HydrogenPro, as a fast-growing global green hydrogen technology company, will be able to speed up its technology offering to the European market.

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (19/04/2023)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #681: Do&Co feiert Rekord in Umsatz, Ergebnis und Aktienkurs, wir feiern AC/DC und next year alle gemeinsam

Bildnachweis

1. Andritz, Ankunft der ersten Komponenten: Das Kidston Pumped Storage Hydro Project (K2-Hydro) mit einer Leistung von 250 MW ist das erste Pumpspeicherkraftwerk in Australien seit über 40 Jahren, das erste, das privat entwickelt wurde, und die drittgrößte Stromspeicheranlage des Landes. Credit: Andritz , (© Aussender)   >> Öffnen auf photaq.com

Aktien auf dem Radar:Immofinanz, Warimpex, Addiko Bank, Austriacard Holdings AG, Lenzing, Polytec Group, Palfinger, voestalpine, RBI, DO&CO, Josef Manner & Comp. AG, Semperit, UBM, Wolford, Oberbank AG Stamm, Pierer Mobility, Agrana, Amag, CA Immo, Erste Group, EVN, Flughafen Wien, Österreichische Post, Telekom Austria, Uniqa, VIG, Wienerberger.

Random Partner

---

Immofinanz
Die Immofinanz ist ein börsenotierter gewerblicher Immobilienkonzern, der seine Aktivitäten auf die Segmente Einzelhandel und Büro in sieben Kernmärkten in Europa (Österreich, Deutschland, Tschechien, Slowakei, Ungarn, Rumänien und Polen) fokussiert. Zum Kerngeschäft zählen die Bewirtschaftung und die Entwicklung von Immobilien.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner